EuroPCR 2008

EuroPCR08 welcomed an outstanding number of practitioners from all over the world of 10,479 in Barcelona, Spain, from 13-16 May 2008. The programme focused on 2 key messages : "what is best for my patient" and "together we achieve more".

Access the course programme along with the slides here

Highlights of EuroPCR 2008 :

• A royal opening for EuroPCR 2008
  Professor Marco J. FESC, opened EuroPCR 2008 with a reminder of the principal objectives of EuroPCR - to contribute to the advancement of education and information with the aim to reduce the burden of cardiovascular disease. EuroPCR had the privilege and honour to receive H.S.H. Prince Albert of Monaco as special guest at the opening of the Course, concerning a new educational joint programme (EuroPCR, EAPCI and the Principality of Monaco) for cardiovascular education in sub-saharan Africa. Read more...

• Learning the techniques
  For the second year running, these educative sessions were very appreciated by the audience, and covered coronary, carotid and patent foramen ovale percutaneous interventions, with live case transmissions.

• Together we achieve more
  The European Society of Cardiology, the Transcatheter Valve Symposium and the European Association for Cardio-Thoracic Surgery have successfully applied the "together we achieve more" concept, and were an integral part of the scientific programme.
  Patients with aortic stenosis or pulmonary valve disease: the clinician, the cardiac surgeon and the interventionalist - Together we achieve more
  Part I: clinical focus
  Part II: how to start a valve programme
  Read more...

• A major topic covered during the second day of EuroPCR 2008 was the Acute Coronary Syndrome (ACS). The first session in the day’s series, chaired by Professors Weidinger FESC and Bassand FESC was titled “ Management of patients with non-ST segment elevation acute coronary syndromes” and attracted a large audience. Read more...

• Femoral artery disease: optimising endovascular treatment
  The participants of this session highlighted the importance of effective treatments for femoral artery disease, a topic which is still debated by interventionalists and vascular surgeons. Read more...